IPI trademark

Bristol-Myers Squibb Company design mark 18508/2026

Under examinationIPIFigurative markClass 5

"Design mark 18508/2026" is a figurative mark owned by Bristol-Myers Squibb Company, filed at the IPI on October 21, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Bristol-Myers Squibb Company portfolioGet this data via the API
Bristol-Myers Squibb Company design mark 18508/2026 trademark as filed
As filed with the IPI
Status
Under examination
Filed
October 21, 2026
Registered
Not yet
Expires
October 21, 2036
Application no.
18508/2026
Registration no.
Not yet
Office
IPI
Swiss Federal Institute of Intellectual Property
Mark type
Figurative mark
1 class
Ownership

Who owns Bristol-Myers Squibb Company design mark 18508/2026

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Bristol-Myers Squibb Company

BMY · United States

6,627 trademarks in the portfolioView company

Representative

Troller Hitz Troller, Rechtsanwälte

Goods and services

What the mark covers

The products and services Bristol-Myers Squibb Company design mark 18508/2026 is filed for, grouped by Nice class.

  • Pharmazeutische Präparate zur Behandlung und Vorbeugung von Fettleibigkeit, Herz-Kreislauf-Erkrankungen, Erkrankungen des zentralen Nervensystems, Stoffwechselstörungen, Schlaganfall, Krebs, Entzündungskrankheiten, Atemwegserkrankungen, Infektionskrankheiten, Autoimmunkrankheiten, Abstossung von Transplantaten fester Organe, autoinflammatorischen Erkrankungen, Blutkrankheiten, Multipler Sklerose, Colitis ulcerosa, cystischer Fibrose, Arthritis, Alzheimer-Krankheit, Autismus-Spektrum-Störung, Muskel-Skelett-Erkrankungen und Hauterkrankungen; antivirale Mittel; Antikörper für medizinische Zwecke; biologische Präparate für die Behandlung von Krebs; Antikoagulantien; Stammzellen für medizinische Zwecke; radiopharmazeutische Präparate für die Behandlung von Krebs und soliden Tumoren; diagnostische radiopharmazeutische Präparate; diagnostische Präparate für medizinische Zwecke.

FAQ

About Bristol-Myers Squibb Company design mark 18508/2026

Who owns the trademark "Design mark 18508/2026"?

The IPI trademark "Design mark 18508/2026" (application 18508/2026) is owned by Bristol-Myers Squibb Company.

What is the status of "Design mark 18508/2026"?

Its status at the IPI is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Bristol-Myers Squibb Company design mark 18508/2026 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a15efc-1572-7275-b744-c20a0296cb92
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a15efc-1572-7275-b744-c20a0296cb92",
  "object": "trademark",
  "mark_text": "((fig.))",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "CH",
  "application_number": "18508/2026",
  "filing_date": "2026-10-21",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Bristol-Myers Squibb Company",
      "entity_id": "ent_019eb6f6-138d-72ab-8c30-1f28aa1b6803"
    }
  ]
}